StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)

StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

ATHX opened at $0.00 on Monday. The firm has a market cap of $283,907.40, a price-to-earnings ratio of 0.00 and a beta of -0.90. Athersys has a fifty-two week low of $0.01 and a fifty-two week high of $1.99. The company’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.02.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.